Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min
Statement | 01 February 2023 Diagnostics MSF Statement on EB152/5 - Strengthening diagnostics capacity 1 min
Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min
Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min
Statement | 11 November 2021 COVID-19 MSF position on the scope and duration of the TRIPS waiver for COVID-19
Photograph by Diego Baravelli Statement Statement | 03 September 2021 COVID-19 G20 leaders must demonstrate real-time international cooperation and action to control the ongoing COVID-19 pandemic 5 min
